Firdapse 10 MG
Ended Awarded
- Contract number
- 36C24526N0193
- Awardee
-
Catalyst Pharmaceuticals, Inc. UEI J1B2ARLKWN53
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $18,978
Award facts
- Contract value 100% obligated
- $18,978.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
Catalyst Pharmaceuticals, Inc. was awarded a delivery order valued at $18,978.13 by Veterans Integrated Service Network 5 (VISN 5), a civilian agency within the Department of Veterans Affairs, for the supply of Firdapse 10 mg tablets. This contract, effective December 17, 2025, with an ultimate completion date of December 19, 2025, operates under a firm fixed-price model and carries no set-aside designation. The award is placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract and draws from Catalyst Pharmaceuticals' $5.5 million Blanket Purchase Agreement with the VA National Acquisition Center, valid through July 25, 2026. The performance location is Bartlett, Tennessee.
Firdapse (amifampridine) is an FDA-approved pharmaceutical treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder. Catalyst Pharmaceuticals has established itself as a specialized supplier to the VA healthcare system, with Firdapse 10 mg tablets representing the cornerstone of its federal contract portfolio across multiple Veterans Integrated Service Networks. The company serves as the prime contractor on this delivery order with no identified subcontractors, consistent with its historical contracting patterns within the federal healthcare marketplace.
Quick answers
Who was awarded contract 36C24526N0193?
36C24526N0193 was awarded to Catalyst Pharmaceuticals, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 17, 2025.
How much is contract 36C24526N0193 worth?
The government has obligated $18,978 on 36C24526N0193.
Is contract 36C24526N0193 an order under another contract?
Yes. 36C24526N0193 is a delivery order under 36F79719D0160, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0193 competed?
The extent of competition for 36C24526N0193 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award